Literature DB >> 32125094

Mitigation of radiation-induced hematopoietic system injury by melatonin.

Peyman Amini1, Milad Ashrafizadeh2, Elahe Motevaseli3, Masoud Najafi4, Alireza Shirazi5.   

Abstract

BACKGROUND: Increased risks of exposure to accidental radiation events are a concern in today's world. Radiation terror, nuclear explosion, as well as accidental exposure to radioactive sources in some industries pose a threat to the life of exposed persons. Studies have been conducted using some low-toxic agents to mitigate radiation toxicity and increase survival probability for exposed people. In the current study, we aimed to show the mitigation of radiation-induced mortality and bone marrow toxicity using postirradiation treatment with melatonin.
METHOD: Mice whole bodies were exposed to 4 or 7 Gy radiation followed by treatment with melatonin after 24 hours. Survival of mice with or without melatonin, the levels of peripheral cells, transforming growth factor (TGF)-β and 8-hydroxy-2' -deoxyguanosine (8-OHdG) in the bone marrow, as well as the expression of NADPH oxidase (NOX)2 and NOX4 in bone marrow cells were evaluated.
RESULTS: Whole body irradiation led to mortality 30 days after irradiation. However, melatonin treatment reduced mortality. Irradiation also showed severe reduction of lymphocytes, platelets, and red blood cells. The expressions of NOX2 and NOX4, in addition to TGF-β level, were increased after exposure to radiation. Melatonin ameliorated the increased levels of these factors and improved the number of blood cells.
CONCLUSIONS: Melatonin showed ability to mitigate radiation-induced hematopoietic system toxicity and also increased survival rate. These results suggest that melatonin could be a potential mitigator for accidental radiation events.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  NOX2; NOX4; hematopoietic system; melatonin; mitigation; radiation

Year:  2020        PMID: 32125094     DOI: 10.1002/tox.22917

Source DB:  PubMed          Journal:  Environ Toxicol        ISSN: 1520-4081            Impact factor:   4.119


  6 in total

Review 1.  Protection of the hematopoietic system against radiation-induced damage: drugs, mechanisms, and developments.

Authors:  Yuanyun Wei; Yaqi Gong; Shuang Wei; Yonglin Chen; Jian Cui; Xiang Lin; Yueqiu Yu; Hongxia Yan; Hui Qin; Lan Yi
Journal:  Arch Pharm Res       Date:  2022-08-11       Impact factor: 6.010

2.  Animal study of a newly designed metal airway brachytherapy stent loaded with radioactive 125I seeds.

Authors:  Dechao Jiao; Qinyu Lei; Kaihao Xu; Yiming Liu; Xinwei Han
Journal:  J Cancer Res Clin Oncol       Date:  2022-01-03       Impact factor: 4.322

Review 3.  Targeting of cancer cell death mechanisms by resveratrol: a review.

Authors:  Xiao Fu; Mu Li; Cuilian Tang; Zezhi Huang; Masoud Najafi
Journal:  Apoptosis       Date:  2021-09-25       Impact factor: 4.677

4.  Sitagliptin Mitigates Total Body Irradiation-Induced Hematopoietic Injury in Mice.

Authors:  Meifang Wang; Yinping Dong; Jing Wu; Hongyan Li; Junling Zhang; Lu Lu; Yuanyang Zhang; Zewei Zhou; Saijun Fan; Deguan Li; Aimin Meng
Journal:  Oxid Med Cell Longev       Date:  2020-07-25       Impact factor: 6.543

5.  Prophylactic treatment with transdermal deferoxamine mitigates radiation-induced skin fibrosis.

Authors:  Abra H Shen; Mimi R Borrelli; Sandeep Adem; Nestor M Diaz Deleon; Ronak A Patel; Shamik Mascharak; Sara J Yen; Blake Y Sun; Walter L Taylor; Michael Januszyk; Dung H Nguyen; Arash Momeni; Geoffrey C Gurtner; Michael T Longaker; Derrick C Wan
Journal:  Sci Rep       Date:  2020-07-23       Impact factor: 4.996

6.  Radiation exposure induces cross-species temporal metabolic changes that are mitigated in mice by amifostine.

Authors:  Alexandra Crook; Aline De Lima Leite; Thomas Payne; Fatema Bhinderwala; Jade Woods; Vijay K Singh; Robert Powers
Journal:  Sci Rep       Date:  2021-07-07       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.